Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Werns

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of the American College of Cardiology|April 1, 1987
Superoxide dismutase does not cause scar thinning after myocardial infarctionS W Werns, M J Shea, A Vaporciyan, et al.
The American Journal of Cardiology|April 4, 1998
Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventionsM Moscucci, M Ricciardi, K A Eagle, et al.
The American Journal of Cardiology|April 1, 1995
Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal diseaseG Reis, P A Marcovitz, A B Leichtman, et al.
Journal of the American College of Cardiology|May 1, 1989
Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarctionS G Ellis, W W O'Neill, E R Bates, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Protection of reperfused ischemic canine myocardium by CI-922, a new inhibitor of leukocyte activationS W Werns, B T Eller, M J Shea, et al.
Circulation|March 1, 1986
Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heartS W Werns, M J Shea, S E Mitsos, et al.
American Heart Journal|October 31, 2001
Predictors of length of stay after coronary stentingH D Aronow, P A Peyser, K A Eagle, et al.
Circulation|March 1, 1991
Xanthine oxidase inhibition does not limit canine infarct sizeS W Werns, C M Grum, A Ventura, et al.
Journal of the American College of Cardiology|February 1, 1991
A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarctionE G Nabel, E J Topol, A Galeana, et al.
Journal of the American College of Cardiology|September 14, 1999
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data setM Moscucci, G T O'Connor, S G Ellis, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of the American College of Cardiology|April 1, 1987
Superoxide dismutase does not cause scar thinning after myocardial infarctionS W Werns, M J Shea, A Vaporciyan, et al.
The American Journal of Cardiology|April 4, 1998
Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventionsM Moscucci, M Ricciardi, K A Eagle, et al.
The American Journal of Cardiology|April 1, 1995
Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal diseaseG Reis, P A Marcovitz, A B Leichtman, et al.
Journal of the American College of Cardiology|May 1, 1989
Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarctionS G Ellis, W W O'Neill, E R Bates, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Protection of reperfused ischemic canine myocardium by CI-922, a new inhibitor of leukocyte activationS W Werns, B T Eller, M J Shea, et al.
Circulation|March 1, 1986
Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heartS W Werns, M J Shea, S E Mitsos, et al.
American Heart Journal|October 31, 2001
Predictors of length of stay after coronary stentingH D Aronow, P A Peyser, K A Eagle, et al.
Circulation|March 1, 1991
Xanthine oxidase inhibition does not limit canine infarct sizeS W Werns, C M Grum, A Ventura, et al.
Journal of the American College of Cardiology|February 1, 1991
A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarctionE G Nabel, E J Topol, A Galeana, et al.
Journal of the American College of Cardiology|September 14, 1999
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data setM Moscucci, G T O'Connor, S G Ellis, et al.
Pageof 4